MapLight Therapeutics, Inc. (MPLT) has an average rating of Buy and mean price target of $39.55, according to analysts polled by FactSet.
What else is happening in Research?
Research
Barrington Initiates CBIZ at Outperform With $45 Price Target
CBIZ (CBZ) has an average rating of overweight and mean price target of $41.80, according to analysts polled by FactSet.Price: $30.50, Change: $+0.10, Percent Change: +0.33%
$CBZ
Research
Stifel Downgrades Apogee Therapeutics to Hold From Buy, Adjusts Price Target to $135 From $133
Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $132.64, according to analysts polled by FactSet.Price: $132.93, Change: $+0.05, Percent Change: +0.04%
$APGE
Research
Rothschild & Co Redburn Cuts TUI Group's PT, Affirms Buy Rating
Rothschild & Co Redburn on Wednesday lowered the price target for German travel services company TUI Group (TUI1.F) to 11.00 euros from 13.60 euros and kept its rating at buy.
$TUI1.F